Perspective Therapeutics Profit Margin

The latest profit margin for CATX is -69438.98% as of September 2026. That compares with -15857.83% in the prior-year period — down 337.9% year over year. That is below the Industrials sector average of 8.38%. Investors often review this figure alongside Perspective Therapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CATX's profit margin moved from -15857.83% to -69438.98% — a 337.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Perspective Therapeutics's valuation or profitability profile.

Against Industrials companies, CATX currently prints -69438.98% for profit margin, while the sector average sits near 8.38%. That is roughly 828817.1% below the sector mean. Large gaps often invite a closer look at Perspective Therapeutics's growth, margins, and balance sheet.

Profit Margin shows how effectively Perspective Therapeutics converts resources into returns. At -69438.98%, CATX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -15857.83% in the prior-year period — down 337.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CATX's profit margin (-69438.98%), review year-over-year change from -15857.83%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.